ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intravenous Iron Drugs Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-8A11521
Home | Market Reports | Health| Pharmacy
Global Intravenous Iron Drugs Market Research Report 2022
BUY CHAPTERS

Global Intravenous Iron Drugs Market Research Report 2025

Code: QYRE-Auto-8A11521
Report
August 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Allergan plc
AMAG Pharmaceuticals
Daiichi Sankyo
Galenica Ltd
Pharmacosmos
Nippon Shinyaku
NOXXON Pharma
Rockwell Medical
Sanofi
Wanbang Biopharmaceutical

Intravenous Iron Drugs Market Size

The global market for Intravenous Iron Drugs was valued at US$ 1611 million in the year 2024 and is projected to reach a revised size of US$ 2126 million by 2031, growing at a CAGR of 4.1% during the forecast period.

Intravenous Iron Drugs Market

Intravenous Iron Drugs Market

Iron is an essential element as it plays an important role in many vital biological processes such as the synthesis of heme which forms the basis of hemoglobin (Hb) the oxygen-carrying protein of the blood, the formation of myoglobin, energy metabolism, neurotransmitter production, the formation of collagen and immune system function. Lack of iron is one of the principal causes of anemia in the general population. It is not surprising that iron deficiency anemia (IDA) is associated with increased morbidity and mortality.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intravenous Iron Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Iron Drugs.
The Intravenous Iron Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intravenous Iron Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Iron Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Intravenous Iron Drugs Market Report

Report Metric Details
Report Name Intravenous Iron Drugs Market
Accounted market size in year US$ 1611 million
Forecasted market size in 2031 US$ 2126 million
CAGR 4.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Ferric Gluconate
  • Ferric Carboxymaltose
  • Iron Sucrose
  • Iron Dextran
Segment by Application
  • Nephrology
  • Gynecology & Obstetrics
  • Gastroenterology
  • Oncology
  • Cardiology
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Allergan, AMAG Pharmaceuticals, Daiichi Sankyo, Galenica, Pharmacosmos, Nippon Shinyaku, NOXXON Pharma, Rockwell Medical, Sanofi, Wanbang Biopharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Intravenous Iron Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Intravenous Iron Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Intravenous Iron Drugs Market growing?

Ans: The Intravenous Iron Drugs Market witnessing a CAGR of 4.1% during the forecast period 2025-2031.

What is the Intravenous Iron Drugs Market size in 2031?

Ans: The Intravenous Iron Drugs Market size in 2031 will be US$ 2126 million.

Who are the main players in the Intravenous Iron Drugs Market report?

Ans: The main players in the Intravenous Iron Drugs Market are Allergan, AMAG Pharmaceuticals, Daiichi Sankyo, Galenica, Pharmacosmos, Nippon Shinyaku, NOXXON Pharma, Rockwell Medical, Sanofi, Wanbang Biopharmaceutical

What are the Application segmentation covered in the Intravenous Iron Drugs Market report?

Ans: The Applications covered in the Intravenous Iron Drugs Market report are Nephrology, Gynecology & Obstetrics, Gastroenterology, Oncology, Cardiology, Others

What are the Type segmentation covered in the Intravenous Iron Drugs Market report?

Ans: The Types covered in the Intravenous Iron Drugs Market report are Ferric Gluconate, Ferric Carboxymaltose, Iron Sucrose, Iron Dextran

1 Intravenous Iron Drugs Market Overview
1.1 Product Definition
1.2 Intravenous Iron Drugs by Type
1.2.1 Global Intravenous Iron Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Ferric Gluconate
1.2.3 Ferric Carboxymaltose
1.2.4 Iron Sucrose
1.2.5 Iron Dextran
1.3 Intravenous Iron Drugs by Application
1.3.1 Global Intravenous Iron Drugs Market Value by Application (2024 VS 2031)
1.3.2 Nephrology
1.3.3 Gynecology & Obstetrics
1.3.4 Gastroenterology
1.3.5 Oncology
1.3.6 Cardiology
1.3.7 Others
1.4 Global Intravenous Iron Drugs Market Size Estimates and Forecasts
1.4.1 Global Intravenous Iron Drugs Revenue 2020-2031
1.4.2 Global Intravenous Iron Drugs Sales 2020-2031
1.4.3 Global Intravenous Iron Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Intravenous Iron Drugs Market Competition by Manufacturers
2.1 Global Intravenous Iron Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Intravenous Iron Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Intravenous Iron Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Intravenous Iron Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intravenous Iron Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravenous Iron Drugs, Product Type & Application
2.7 Global Key Manufacturers of Intravenous Iron Drugs, Date of Enter into This Industry
2.8 Global Intravenous Iron Drugs Market Competitive Situation and Trends
2.8.1 Global Intravenous Iron Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Intravenous Iron Drugs Players Market Share by Revenue
2.8.3 Global Intravenous Iron Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intravenous Iron Drugs Market Scenario by Region
3.1 Global Intravenous Iron Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Intravenous Iron Drugs Sales by Region: 2020-2031
3.2.1 Global Intravenous Iron Drugs Sales by Region: 2020-2025
3.2.2 Global Intravenous Iron Drugs Sales by Region: 2026-2031
3.3 Global Intravenous Iron Drugs Revenue by Region: 2020-2031
3.3.1 Global Intravenous Iron Drugs Revenue by Region: 2020-2025
3.3.2 Global Intravenous Iron Drugs Revenue by Region: 2026-2031
3.4 North America Intravenous Iron Drugs Market Facts & Figures by Country
3.4.1 North America Intravenous Iron Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Intravenous Iron Drugs Sales by Country (2020-2031)
3.4.3 North America Intravenous Iron Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intravenous Iron Drugs Market Facts & Figures by Country
3.5.1 Europe Intravenous Iron Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Intravenous Iron Drugs Sales by Country (2020-2031)
3.5.3 Europe Intravenous Iron Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous Iron Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Intravenous Iron Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Intravenous Iron Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Intravenous Iron Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Intravenous Iron Drugs Market Facts & Figures by Country
3.7.1 Latin America Intravenous Iron Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Intravenous Iron Drugs Sales by Country (2020-2031)
3.7.3 Latin America Intravenous Iron Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous Iron Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous Iron Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Intravenous Iron Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Intravenous Iron Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Intravenous Iron Drugs Sales by Type (2020-2031)
4.1.1 Global Intravenous Iron Drugs Sales by Type (2020-2025)
4.1.2 Global Intravenous Iron Drugs Sales by Type (2026-2031)
4.1.3 Global Intravenous Iron Drugs Sales Market Share by Type (2020-2031)
4.2 Global Intravenous Iron Drugs Revenue by Type (2020-2031)
4.2.1 Global Intravenous Iron Drugs Revenue by Type (2020-2025)
4.2.2 Global Intravenous Iron Drugs Revenue by Type (2026-2031)
4.2.3 Global Intravenous Iron Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Intravenous Iron Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Intravenous Iron Drugs Sales by Application (2020-2031)
5.1.1 Global Intravenous Iron Drugs Sales by Application (2020-2025)
5.1.2 Global Intravenous Iron Drugs Sales by Application (2026-2031)
5.1.3 Global Intravenous Iron Drugs Sales Market Share by Application (2020-2031)
5.2 Global Intravenous Iron Drugs Revenue by Application (2020-2031)
5.2.1 Global Intravenous Iron Drugs Revenue by Application (2020-2025)
5.2.2 Global Intravenous Iron Drugs Revenue by Application (2026-2031)
5.2.3 Global Intravenous Iron Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Intravenous Iron Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Company Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Intravenous Iron Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Allergan Intravenous Iron Drugs Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 AMAG Pharmaceuticals
6.2.1 AMAG Pharmaceuticals Company Information
6.2.2 AMAG Pharmaceuticals Description and Business Overview
6.2.3 AMAG Pharmaceuticals Intravenous Iron Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AMAG Pharmaceuticals Intravenous Iron Drugs Product Portfolio
6.2.5 AMAG Pharmaceuticals Recent Developments/Updates
6.3 Daiichi Sankyo
6.3.1 Daiichi Sankyo Company Information
6.3.2 Daiichi Sankyo Description and Business Overview
6.3.3 Daiichi Sankyo Intravenous Iron Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Daiichi Sankyo Intravenous Iron Drugs Product Portfolio
6.3.5 Daiichi Sankyo Recent Developments/Updates
6.4 Galenica
6.4.1 Galenica Company Information
6.4.2 Galenica Description and Business Overview
6.4.3 Galenica Intravenous Iron Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Galenica Intravenous Iron Drugs Product Portfolio
6.4.5 Galenica Recent Developments/Updates
6.5 Pharmacosmos
6.5.1 Pharmacosmos Company Information
6.5.2 Pharmacosmos Description and Business Overview
6.5.3 Pharmacosmos Intravenous Iron Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pharmacosmos Intravenous Iron Drugs Product Portfolio
6.5.5 Pharmacosmos Recent Developments/Updates
6.6 Nippon Shinyaku
6.6.1 Nippon Shinyaku Company Information
6.6.2 Nippon Shinyaku Description and Business Overview
6.6.3 Nippon Shinyaku Intravenous Iron Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Nippon Shinyaku Intravenous Iron Drugs Product Portfolio
6.6.5 Nippon Shinyaku Recent Developments/Updates
6.7 NOXXON Pharma
6.7.1 NOXXON Pharma Company Information
6.7.2 NOXXON Pharma Description and Business Overview
6.7.3 NOXXON Pharma Intravenous Iron Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 NOXXON Pharma Intravenous Iron Drugs Product Portfolio
6.7.5 NOXXON Pharma Recent Developments/Updates
6.8 Rockwell Medical
6.8.1 Rockwell Medical Company Information
6.8.2 Rockwell Medical Description and Business Overview
6.8.3 Rockwell Medical Intravenous Iron Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Rockwell Medical Intravenous Iron Drugs Product Portfolio
6.8.5 Rockwell Medical Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Company Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Intravenous Iron Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sanofi Intravenous Iron Drugs Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 Wanbang Biopharmaceutical
6.10.1 Wanbang Biopharmaceutical Company Information
6.10.2 Wanbang Biopharmaceutical Description and Business Overview
6.10.3 Wanbang Biopharmaceutical Intravenous Iron Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Wanbang Biopharmaceutical Intravenous Iron Drugs Product Portfolio
6.10.5 Wanbang Biopharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous Iron Drugs Industry Chain Analysis
7.2 Intravenous Iron Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous Iron Drugs Production Mode & Process Analysis
7.4 Intravenous Iron Drugs Sales and Marketing
7.4.1 Intravenous Iron Drugs Sales Channels
7.4.2 Intravenous Iron Drugs Distributors
7.5 Intravenous Iron Drugs Customer Analysis
8 Intravenous Iron Drugs Market Dynamics
8.1 Intravenous Iron Drugs Industry Trends
8.2 Intravenous Iron Drugs Market Drivers
8.3 Intravenous Iron Drugs Market Challenges
8.4 Intravenous Iron Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Allergan plc
AMAG Pharmaceuticals
Daiichi Sankyo
Galenica Ltd
Pharmacosmos
Nippon Shinyaku
NOXXON Pharma
Rockwell Medical
Sanofi
Wanbang Biopharmaceutical
List of Tables
 Table 1. Global Intravenous Iron Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Intravenous Iron Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Intravenous Iron Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Intravenous Iron Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Intravenous Iron Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Intravenous Iron Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Intravenous Iron Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Intravenous Iron Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Intravenous Iron Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Intravenous Iron Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Intravenous Iron Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Intravenous Iron Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Intravenous Iron Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Iron Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Intravenous Iron Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Intravenous Iron Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Intravenous Iron Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Intravenous Iron Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Intravenous Iron Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Intravenous Iron Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Intravenous Iron Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Intravenous Iron Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Intravenous Iron Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Intravenous Iron Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Intravenous Iron Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Intravenous Iron Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Intravenous Iron Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Intravenous Iron Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Intravenous Iron Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Intravenous Iron Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Intravenous Iron Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Intravenous Iron Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Intravenous Iron Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Intravenous Iron Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Intravenous Iron Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Intravenous Iron Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Intravenous Iron Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Intravenous Iron Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Intravenous Iron Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Intravenous Iron Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Intravenous Iron Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Intravenous Iron Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Intravenous Iron Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Intravenous Iron Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Intravenous Iron Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Intravenous Iron Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Intravenous Iron Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Intravenous Iron Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Intravenous Iron Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Intravenous Iron Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Intravenous Iron Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Intravenous Iron Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Intravenous Iron Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Intravenous Iron Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Intravenous Iron Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Intravenous Iron Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Intravenous Iron Drugs Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Intravenous Iron Drugs Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Intravenous Iron Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Intravenous Iron Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Intravenous Iron Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Intravenous Iron Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Intravenous Iron Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Intravenous Iron Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Intravenous Iron Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Intravenous Iron Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Intravenous Iron Drugs Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Intravenous Iron Drugs Price (USD/Unit) by Application (2026-2031)
 Table 70. Allergan Company Information
 Table 71. Allergan Description and Business Overview
 Table 72. Allergan Intravenous Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Allergan Intravenous Iron Drugs Product
 Table 74. Allergan Recent Developments/Updates
 Table 75. AMAG Pharmaceuticals Company Information
 Table 76. AMAG Pharmaceuticals Description and Business Overview
 Table 77. AMAG Pharmaceuticals Intravenous Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. AMAG Pharmaceuticals Intravenous Iron Drugs Product
 Table 79. AMAG Pharmaceuticals Recent Developments/Updates
 Table 80. Daiichi Sankyo Company Information
 Table 81. Daiichi Sankyo Description and Business Overview
 Table 82. Daiichi Sankyo Intravenous Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Daiichi Sankyo Intravenous Iron Drugs Product
 Table 84. Daiichi Sankyo Recent Developments/Updates
 Table 85. Galenica Company Information
 Table 86. Galenica Description and Business Overview
 Table 87. Galenica Intravenous Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Galenica Intravenous Iron Drugs Product
 Table 89. Galenica Recent Developments/Updates
 Table 90. Pharmacosmos Company Information
 Table 91. Pharmacosmos Description and Business Overview
 Table 92. Pharmacosmos Intravenous Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Pharmacosmos Intravenous Iron Drugs Product
 Table 94. Pharmacosmos Recent Developments/Updates
 Table 95. Nippon Shinyaku Company Information
 Table 96. Nippon Shinyaku Description and Business Overview
 Table 97. Nippon Shinyaku Intravenous Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Nippon Shinyaku Intravenous Iron Drugs Product
 Table 99. Nippon Shinyaku Recent Developments/Updates
 Table 100. NOXXON Pharma Company Information
 Table 101. NOXXON Pharma Description and Business Overview
 Table 102. NOXXON Pharma Intravenous Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. NOXXON Pharma Intravenous Iron Drugs Product
 Table 104. NOXXON Pharma Recent Developments/Updates
 Table 105. Rockwell Medical Company Information
 Table 106. Rockwell Medical Description and Business Overview
 Table 107. Rockwell Medical Intravenous Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Rockwell Medical Intravenous Iron Drugs Product
 Table 109. Rockwell Medical Recent Developments/Updates
 Table 110. Sanofi Company Information
 Table 111. Sanofi Description and Business Overview
 Table 112. Sanofi Intravenous Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Sanofi Intravenous Iron Drugs Product
 Table 114. Sanofi Recent Developments/Updates
 Table 115. Wanbang Biopharmaceutical Company Information
 Table 116. Wanbang Biopharmaceutical Description and Business Overview
 Table 117. Wanbang Biopharmaceutical Intravenous Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Wanbang Biopharmaceutical Intravenous Iron Drugs Product
 Table 119. Wanbang Biopharmaceutical Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Intravenous Iron Drugs Distributors List
 Table 123. Intravenous Iron Drugs Customers List
 Table 124. Intravenous Iron Drugs Market Trends
 Table 125. Intravenous Iron Drugs Market Drivers
 Table 126. Intravenous Iron Drugs Market Challenges
 Table 127. Intravenous Iron Drugs Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Intravenous Iron Drugs
 Figure 2. Global Intravenous Iron Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Intravenous Iron Drugs Market Share by Type: 2024 & 2031
 Figure 4. Ferric Gluconate Product Picture
 Figure 5. Ferric Carboxymaltose Product Picture
 Figure 6. Iron Sucrose Product Picture
 Figure 7. Iron Dextran Product Picture
 Figure 8. Global Intravenous Iron Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Intravenous Iron Drugs Market Share by Application: 2024 & 2031
 Figure 10. Nephrology
 Figure 11. Gynecology & Obstetrics
 Figure 12. Gastroenterology
 Figure 13. Oncology
 Figure 14. Cardiology
 Figure 15. Others
 Figure 16. Global Intravenous Iron Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Intravenous Iron Drugs Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Intravenous Iron Drugs Sales (2020-2031) & (K Units)
 Figure 19. Global Intravenous Iron Drugs Average Price (USD/Unit) & (2020-2031)
 Figure 20. Intravenous Iron Drugs Report Years Considered
 Figure 21. Intravenous Iron Drugs Sales Share by Manufacturers in 2024
 Figure 22. Global Intravenous Iron Drugs Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Intravenous Iron Drugs Players: Market Share by Revenue in Intravenous Iron Drugs in 2024
 Figure 24. Intravenous Iron Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Intravenous Iron Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Intravenous Iron Drugs Sales Market Share by Country (2020-2031)
 Figure 27. North America Intravenous Iron Drugs Revenue Market Share by Country (2020-2031)
 Figure 28. U.S. Intravenous Iron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Intravenous Iron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Intravenous Iron Drugs Sales Market Share by Country (2020-2031)
 Figure 31. Europe Intravenous Iron Drugs Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Intravenous Iron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Intravenous Iron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Intravenous Iron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Intravenous Iron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Intravenous Iron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Intravenous Iron Drugs Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Intravenous Iron Drugs Revenue Market Share by Region (2020-2031)
 Figure 39. China Intravenous Iron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Intravenous Iron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Intravenous Iron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Intravenous Iron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Intravenous Iron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Taiwan Intravenous Iron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia Intravenous Iron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand Intravenous Iron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia Intravenous Iron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Philippines Intravenous Iron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Intravenous Iron Drugs Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Intravenous Iron Drugs Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Intravenous Iron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Intravenous Iron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Intravenous Iron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Intravenous Iron Drugs Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Intravenous Iron Drugs Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Intravenous Iron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Intravenous Iron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. U.A.E Intravenous Iron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Intravenous Iron Drugs by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Intravenous Iron Drugs by Type (2020-2031)
 Figure 61. Global Intravenous Iron Drugs Price (USD/Unit) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Intravenous Iron Drugs by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Intravenous Iron Drugs by Application (2020-2031)
 Figure 64. Global Intravenous Iron Drugs Price (USD/Unit) by Application (2020-2031)
 Figure 65. Intravenous Iron Drugs Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions